The role of m6A demethylases in lung cancer: diagnostic and therapeutic implications.

Mengjiao Yu, Wenqian Ji, Xu Yang, Kai Tian, Xinyi Ma, Shali Yu, Lin Chen, Xinyuan Zhao

Journal: Frontiers in immunology 2023;14():1279735

PMID: 38094306

Abstract

m6A is the most prevalent internal modification of eukaryotic mRNA, and plays a crucial role in tumorigenesis and various other biological processes. Lung cancer is a common primary malignant tumor of the lungs, which involves multiple factors in its occurrence and progression. Currently, only the demethylases FTO and ALKBH5 have been identified as associated with m6A modification. These demethylases play a crucial role in regulating the growth and invasion of lung cancer cells by removing methyl groups, thereby influencing stability and translation efficiency of mRNA. Furthermore, they participate in essential biological signaling pathways, making them potential targets for intervention in lung cancer treatment. Here we provides an overview of the involvement of m6A demethylase in lung cancer, as well as their potential application in the diagnosis, prognosis and treatment of the disease.

Copyright © 2023 Yu, Ji, Yang, Tian, Ma, Yu, Chen and Zhao.

Address: Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong, China.; College of International Studies, Southwest University, Chongqing, China.; Nantong Institute of Liver Diseases, Nantong Third People's Hospital Affiliated Nantong Hospital of Nantong University, Nantong, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.